Concise summaries of everything published in the latest weekly issue of the New England Journal of Medicine (NEJM). NEJM publishes new medical research findings, review articles, and editorial opinion on topics of importance to biomedical science and clinical practice.
…
continue reading
Content provided by CReATe Consortium. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CReATe Consortium or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
ALS Untangled Series Ep. 56 - Sodium Chlorite
MP3•Episode home
Manage episode 384006839 series 2119718
Content provided by CReATe Consortium. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CReATe Consortium or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Sodium chlorite is an experimental drug targeting macrophage activation. It exists in different formulations. An oral formulation has potentially deadly side effects. An IV formulation called NP001 has been in recent trials targeting a subset of people with ALS. Here we review the interesting development of this product and where we expect that to go in the near future.
…
continue reading
77 episodes
MP3•Episode home
Manage episode 384006839 series 2119718
Content provided by CReATe Consortium. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CReATe Consortium or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Sodium chlorite is an experimental drug targeting macrophage activation. It exists in different formulations. An oral formulation has potentially deadly side effects. An IV formulation called NP001 has been in recent trials targeting a subset of people with ALS. Here we review the interesting development of this product and where we expect that to go in the near future.
…
continue reading
77 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.